University of Tennessee Health Science Center, College of Dentistry, Department of Bioscience Research, Memphis, Tennessee.
University of Tennessee Health Science Center, College of Dentistry, Department of Bioscience Research, Memphis, Tennessee.
J Endod. 2020 Sep;46(9S):S128-S134. doi: 10.1016/j.joen.2020.06.020.
Stem cell-mediated regenerative endodontics has reached the human clinical trial phase; however, many issues still exist that prevent such technology to be a widely used clinical practice. These issues are not straightforward and are complicated. They should be because pulp regeneration is dealing with a small dead-end space. In addition, when regeneration is needed, the space is often heavily infected. The true standard of pulp regeneration should be everything except generation of some fibrous connective tissue and amorphous mineral deposit. As of now, we are still far short of reaching the standard of complete vascularized and innervated pulp regeneration with newly formed tubular dentin in all types of teeth. Thus, we need to go back to the bench and use established animal models or create new animal models to tackle those issues. This article will address several key issues including the possibility of pulp regeneration in small canals of molar teeth by enhancing the neovascularization, and whether the organized tubular dentin can be generated on the canal walls. Data from our semi-orthotopic tooth fragment mouse model have shown that complete pulp regeneration using dental pulp stem cells (DPSCs) in small canal has been inconsistent because of limited blood supply. This inconsistency is similar in our orthotopic miniature swine model, although in some cases vascularized pulp-like tissue can be formed throughout the canal space after DPSC transplantation. Furthermore, no tubular dentin was observed in the orthotopic pulp regeneration, despite the fact that DPSCs have the capacity to generate some tubular dentin-like structure in the hydroxyapatite/tricalcium phosphate-mediated ectopic pulp/dentin formation model in mice. Potential strategies to be tested to address these regeneration issues are discussed herein.
牙髓再生的干细胞疗法已经进入了人体临床试验阶段;然而,仍然存在许多问题,这些问题使得该技术无法广泛应用于临床实践。这些问题并不简单,而且很复杂。它们应该是复杂的,因为牙髓再生是在一个小的死腔中进行的。此外,当需要再生时,这个空间通常受到严重感染。牙髓再生的真正标准应该是除了生成一些纤维状结缔组织和无定形矿物质沉积外的一切。到目前为止,我们还远远没有达到在所有类型的牙齿中用新形成的管状牙本质完全再生血管化和神经支配的牙髓的标准。因此,我们需要回到实验室,使用已建立的动物模型或创建新的动物模型来解决这些问题。本文将讨论几个关键问题,包括通过增强新血管生成来实现磨牙小根管内牙髓再生的可能性,以及是否可以在根管壁上生成有组织的管状牙本质。我们的半原位牙片段小鼠模型的数据表明,由于血液供应有限,使用牙髓干细胞(DPSCs)在小根管内进行完全牙髓再生的效果并不一致。这种不一致性在我们的原位小型猪模型中也是如此,尽管在某些情况下,DPSC 移植后可以在整个根管空间形成血管化的牙髓样组织。此外,尽管 DPSCs 在小鼠的羟磷灰石/磷酸三钙介导的异位牙髓/牙本质形成模型中具有生成一些管状牙本质样结构的能力,但在原位牙髓再生中并未观察到管状牙本质。本文讨论了为解决这些再生问题而将被测试的潜在策略。